Drug-induced lung disease: a narrative review.
Bridi GDP, Fonseca EKUN, Kairalla RA, Amaral AF, Baldi BG.
J Bras Pneumol. 2024 Sep 27;50(4):e20240110. doi: 10.36416/1806-3756/e20240110. eCollection 2024.
Progressive pulmonary fibrosis: an expert group consensus statement.
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, Mohan A, Renzoni E, Mohan M, Udwadia Z, Shenoy P, Currow D, Devraj A, Jankharia B, Kulshrestha R, Jones S, Ravaglia C, Quadrelli S, Iyer R, Dhooria S, Kolb M, Wells AU.
Eur Respir J. 2023 Mar 30;61(3):2103187. doi: 10.1183/13993003.03187-2021. Print 2023 Mar.
Pulmonary Complications of Systemic Lupus Erythematosus.
Hannah JR, D'Cruz DP.
Semin Respir Crit Care Med. 2019 Apr;40(2):227-234. doi: 10.1055/s-0039-1685537. Epub 2019 May 28.
Update on cryptogenic organizing pneumonia.
Radzikowska E, Fijolek J.
Front Med (Lausanne). 2023 Apr 20;10:1146782. doi: 10.3389/fmed.2023.1146782. eCollection 2023.
Eosinophilic Pneumonias.
Allen J, Wert M.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1455-1461. doi: 10.1016/j.jaip.2018.03.011. Epub 2018 May 4.
Drug induced pulmonary parenchymal disease.
Prasad R, Gupta P, Singh A, Goel N.
Drug Discov Ther. 2014 Dec;8(6):232-7. doi: 10.5582/ddt.2014.01046.
Iatrogenic pulmonary lesions.
Roden AC, Camus P.
Semin Diagn Pathol. 2018 Jul;35(4):260-271. doi: 10.1053/j.semdp.2018.03.002. Epub 2018 Mar 23.
Drug-induced pulmonary edema and acute respiratory distress syndrome.
Lee-Chiong T Jr, Matthay RA.
Clin Chest Med. 2004 Mar;25(1):95-104. doi: 10.1016/S0272-5231(03)00128-X.
Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.
Kumar K, Holden WE.
West J Med. 1986 Sep;145(3):343-9.
Drug-associated pulmonary arterial hypertension.
McGee M, Whitehead N, Martin J, Collins N.
Clin Toxicol (Phila). 2018 Sep;56(9):801-809. doi: 10.1080/15563650.2018.1447119. Epub 2018 Mar 6.
